Your browser doesn't support javascript.
loading
Optimizing community linkage to care and antiretroviral therapy Initiation: Lessons from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) and their adaptation in Nigeria ART Surge.
Jahun, Ibrahim; Said, Ishaq; El-Imam, Ibrahim; Ehoche, Akipu; Dalhatu, Ibrahim; Yakubu, Aminu; Greby, Stacie; Bronson, Megan; Brown, Kristin; Bamidele, Moyosola; Boyd, Andrew T; Bachanas, Pamela; Dirlikov, Emilio; Agbakwuru, Chinedu; Abutu, Andrew; Williams-Sherlock, Michelle; Onotu, Denis; Odafe, Solomon; Williams, Daniel B; Bassey, Orji; Ogbanufe, Obinna; Onyenuobi, Chibuzor; Adeola, Ayo; Meribe, Chidozie; Efuntoye, Timothy; Fagbamigbe, Omodele J; Fagbemi, Ayodele; Ene, Uzoma; Nguhemen, Tingir; Mgbakor, Ifunanya; Alagi, Matthias; Asaolu, Olugbenga; Oladipo, Ademola; Amafah, Joy; Nzelu, Charles; Dakum, Patrick; Mensah, Charles; Aliyu, Ahmad; Okonkwo, Prosper; Oyeledun, Bolanle; Oko, John; Ikpeazu, Akudo; Gambo, Aliyu; Charurat, Manhattan; Ellerbrock, Tedd; Aliyu, Sani; Swaminathan, Mahesh.
Afiliação
  • Jahun I; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Said I; Maryland Global Initiatives (affiliate of the University of Maryland, Baltimore), Abuja, Federal Capital Territory, Nigeria.
  • El-Imam I; Maryland Global Initiatives (affiliate of the University of Maryland, Baltimore), Abuja, Federal Capital Territory, Nigeria.
  • Ehoche A; Maryland Global Initiatives (affiliate of the University of Maryland, Baltimore), Abuja, Federal Capital Territory, Nigeria.
  • Dalhatu I; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Yakubu A; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Greby S; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Bronson M; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Brown K; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Bamidele M; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Boyd AT; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Bachanas P; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Dirlikov E; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Agbakwuru C; Maryland Global Initiatives (affiliate of the University of Maryland, Baltimore), Abuja, Federal Capital Territory, Nigeria.
  • Abutu A; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Williams-Sherlock M; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Onotu D; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Odafe S; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Williams DB; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Bassey O; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Ogbanufe O; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Onyenuobi C; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Adeola A; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Meribe C; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Efuntoye T; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Fagbamigbe OJ; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Fagbemi A; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Ene U; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Nguhemen T; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Mgbakor I; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Alagi M; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Asaolu O; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Oladipo A; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Amafah J; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
  • Nzelu C; Federal Ministry of Health, Abuja, Nigeria.
  • Dakum P; Institute of Human Virology (IHVN), Abuja, Federal Capital Territory, Nigeria.
  • Mensah C; Institute of Human Virology (IHVN), Abuja, Federal Capital Territory, Nigeria.
  • Aliyu A; Institute of Human Virology (IHVN), Abuja, Federal Capital Territory, Nigeria.
  • Okonkwo P; AIDS Prevention Initiative Nigeria (APIN), Abuja, Federal Capital Territory, Nigeria.
  • Oyeledun B; Center for Integrated Health Program (CIHP), Abuja, Federal Capital Territory, Nigeria.
  • Oko J; Catholic Caritas Foundation Nigeria (CCFN), Abuja, Federal Capital Territory, Nigeria.
  • Ikpeazu A; Federal Ministry of Health, Abuja, Nigeria.
  • Gambo A; National Agency for the Control of AIDS, Abuja, Federal Capital Territory, Nigeria.
  • Charurat M; Maryland Global Initiatives (affiliate of the University of Maryland, Baltimore), Abuja, Federal Capital Territory, Nigeria.
  • Ellerbrock T; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Aliyu S; National Agency for the Control of AIDS, Abuja, Federal Capital Territory, Nigeria.
  • Swaminathan M; Centers for Disease Control and Prevention-Nigeria Country Office, Abuja, Federal Capital Territory, Nigeria.
PLoS One ; 16(9): e0257476, 2021.
Article em En | MEDLINE | ID: mdl-34543306
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Telemedicina / Atenção à Saúde Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male País/Região como assunto: Africa Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Nigéria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Telemedicina / Atenção à Saúde Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male País/Região como assunto: Africa Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Nigéria